Antagonists of bombesin/gastrin-releasing peptide as adjuncts to agonists of luteinizing hormone–releasing hormone in the treatment of experimental prostate cancer

This publication has 31 references indexed in Scilit:

• Inhibition of growth of PC‐82 human prostate cancer line xenografts in nude mice by bombesin antagonist RC‐3095 or combination of agonist [D‐Trp⁶]‐luteinizing hormone‐releasing hormone and somatostatin analog RC‐160
  The Prostate, 1992
• Clinical Study of Leuprolide Depot Formulation in the Treatment of Advanced Prostate Cancer
  Journal of Urology, 1990
• Production of epidermal growth factor and transforming growth factor‐α by the androgen‐responsive LNCaP human prostate cancer cell line
  The Prostate, 1990
• Treatment of Advanced Prostate Cancer
  Hormone Research, 1989
• Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line
  The Prostate, 1989
• LHRH Analogue as a Depot Preparation (Zoladex) in the Treatment of Advanced Carcinoma of the Prostate Followed by Orchiectomy as a Second Line Therapy—A Phase II Study
  Scandinavian Journal of Urology and Nephrology, 1989
• Prostatic Cancer: Aetiology and Endocrinology
  Hormone Research, 1989
• Treatment of Advanced Prostatic Cancer
  Urologic Clinics of North America, 1987
• Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model.
  Proceedings of the National Academy of Sciences, 1985
• The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer
  The Prostate, 1984